STYRON™ 2678 MED Polystyrene Resins can be used for a variety of medical device applications including clear packaging, diagnostic components, petri dishes and housings for test kits.
Highlights of the resin material include excellent transparency (approx. 90% transmission), stiffness, rigidity and heat resistance. Properties supporting medical device applications include biocompatibility, sterilization stability, and chemical resistance to fight infection. The material may also be processed further with secondary operations such as solvent bonding, welding and laser marking, typical for medical devices.
“There’s a growing need - especially within medical packaging – for a medical grade polymer that performs well, protects the product, and provides an added degree of safety,” said Ben Porter, technical service & development engineer, Trinseo, Netherlands. “STYRON™ 2678 MED Polystyrene Resin provides customers with an ideal and economical solution and an alternative to general purpose food grade polystyrene.”
Trinseo has served the global medical devices market with high performance plastics for single- and multiple-use devices and equipment housings for nearly three decades. The company offers worldwide production and fulfillment, recently announcing its medical compounding capability in Asia Pacific to complement existing compounding in Europe and North America.
STYRON™ 2678 MED Polystyrene Resin expands Trinseo’s offering of transparent materials for medical applications.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.8 billion in net sales with 2,700 employees globally in 2019. For more information, please visit: www.trinseo.com.
This press release may contain “forward-looking statements” including, without limitation, statements concerning plans, objectives, goals, projections, expectations, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts. Forward-looking statements may be identified by the use of words like “expect,” “estimate,” “will,” “may,” or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on the Company’s current expectations and assumptions regarding the impact from the COVID-19 pandemic, the Company’s business, the economy and other future conditions. Specific factors that could cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, risks related to the ongoing impact of the COVID-19 pandemic and those discussed in the Company’s Annual Report for the year ended December 31, 2019 filed with the Securities and Exchange Commission (“SEC”), in subsequent Quarterly Reports on Form 10-Q and in other filings and furnishings made by the Company with the SEC from time to time. Other unknown or unpredictable factors could also have material adverse effects on the Company’s performance. As a result of these or other factors, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof and are not a guarantee of future performance. The Company undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.